Organon Co Equity-NMS: OGN

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$6.38
Open :	$6.35
Today's high :	$6.64
Today's low :	$6.33
52W low :	$6.18
52W high :	$16.8437
1Y :	-59.87%
5Y :	-80.27%
EPS(TTM): :	2.69
Shares O/S :	259.97 M
Market cap :	1.71 B

What is the share price of Organon Co today?

Organon Co (OGN) share price as of November 5, 2025, is $6.38. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Organon Co?

Yes, Indian Investors can invest in the Organon Co (OGN) Share by opening an international trading account with Angel One.

How can I purchase Organon Co shares in India?

Purchasing Organon Co (OGN) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Organon Co (OGN) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Organon Co?

Yes, you can purchase fractional shares of Organon Co (OGN) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Organon Co?

The market capitalization of Organon Co on November 5, 2025, is $1.71 B.

In which sector Organon Co belongs?

Organon Co operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

What documents are required to invest in Organon Co stocks?

In order to invest in Organon Co (OGN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.